SI-BONE Inc
NASDAQ:SIBN
SI-BONE Inc
Total Equity
SI-BONE Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SI-BONE Inc
NASDAQ:SIBN
|
Total Equity
$165.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$19.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$19.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$38.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$14B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Total Equity
$751.8m
|
CAGR 3-Years
54%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is SI-BONE Inc's Total Equity?
Total Equity
165.5m
USD
Based on the financial report for Mar 31, 2024, SI-BONE Inc's Total Equity amounts to 165.5m USD.
What is SI-BONE Inc's Total Equity growth rate?
Total Equity CAGR 5Y
15%
Over the last year, the Total Equity growth was 76%. The average annual Total Equity growth rates for SI-BONE Inc have been 1% over the past three years , 15% over the past five years .